Want to see ANRO full AI Analyst Report?
Compare Alto Neuroscience, Inc. (ANRO) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| ANROAlto Neuroscience, Inc. | $21.71 | $886.87M | -9.11 | 56.38% | Strong Buy | Unlock the ANRO analyst price target with TipRanks Premium | ANRO | Unlock the ANRO top-analyst price target with TipRanks Premium | ||
| CRBPCorbus Pharmaceuticals | $3.90 | $81.62M | -0.65 | -67.78% | Strong Buy | Unlock the CRBP analyst price target with TipRanks Premium | ANRO vs CRBP | Unlock the CRBP top-analyst price target with TipRanks Premium | ||
| MISTMilestone Pharmaceuticals | $0.72 | $90.88M | -1.06 | -62.45% | Strong Buy | Unlock the MIST analyst price target with TipRanks Premium | ANRO vs MIST | Unlock the MIST top-analyst price target with TipRanks Premium | ||
| ELTXElicio Therapeutics | $1.58 | $45.51M | -0.79 | -82.88% | Moderate Buy | Unlock the ELTX analyst price target with TipRanks Premium | ANRO vs ELTX | Unlock the ELTX top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | 22.19 | 10.02 | 82.33% | |
| CRBP | Corbus Pharmaceuticals | 3.92 | -8.39 | -68.17% | |
| MIST | Milestone Pharmaceuticals | 0.72 | -1.13 | -61.03% | |
| ELTX | Elicio Therapeutics | 1.59 | -7.66 | -82.81% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
